Pharmacotherapy in fibromyalgia (FM)--implications for the underlying pathophysiology
- PMID: 20388527
- DOI: 10.1016/j.pharmthera.2010.03.002
Pharmacotherapy in fibromyalgia (FM)--implications for the underlying pathophysiology
Abstract
Although chronic pain states are highly prevalent, the underlying neurobiological mechanisms involved in causing pain are incompletely understood. This is especially true for the so-called chronic functional pain syndromes and pain syndromes of unknown origin, such as fibromyalgia (FM), in which no structural correlates of pain experience, in terms of a nociceptive source, can clearly be defined. In addition to limited therapeutic options and often unsatisfactory treatment, such patients often struggle with socio-medical acceptance of their pain condition. As FM has become more widely recognized, options available for treatment have grown along with our understanding of the neurobiological mechanisms underlying chronic pain experience and concomitant symptoms. The current review aims to provide an overview of existing pharmacotherapies for FM, and their implication for the underlying pathophysiology. Further we discuss some of the potential targets that have been recently identified that may hold promise for the development of novel treatments.
2010 Elsevier Inc. All rights reserved.
Similar articles
-
Pharmacotherapy of fibromyalgia.Rheum Dis Clin North Am. 2009 May;35(2):359-72. doi: 10.1016/j.rdc.2009.06.007. Rheum Dis Clin North Am. 2009. PMID: 19647148 Review.
-
Emerging pharmacological therapies for fibromyalgia.Curr Opin Investig Drugs. 2006 Jul;7(7):631-6. Curr Opin Investig Drugs. 2006. PMID: 16869116 Review.
-
Fibromyalgia--management of a misunderstood disorder.J Am Acad Nurse Pract. 2007 Jul;19(7):341-8. doi: 10.1111/j.1745-7599.2007.00235.x. J Am Acad Nurse Pract. 2007. PMID: 17680899 Review.
-
Biomedical models of fibromyalgia.Disabil Rehabil. 2005 Jun 17;27(12):659-65. doi: 10.1080/09638280400009048. Disabil Rehabil. 2005. PMID: 16012058 Review.
-
Strategies for managing fibromyalgia.Am J Med. 2009 Dec;122(12 Suppl):S31-43. doi: 10.1016/j.amjmed.2009.09.009. Am J Med. 2009. PMID: 19962495 Review.
Cited by
-
Gray Matter Atrophy within the Default Mode Network of Fibromyalgia: A Meta-Analysis of Voxel-Based Morphometry Studies.Biomed Res Int. 2016;2016:7296125. doi: 10.1155/2016/7296125. Epub 2016 Dec 26. Biomed Res Int. 2016. PMID: 28105430 Free PMC article. Review.
-
Meeting them where they are: Using the Internet to deliver behavioral medicine interventions for pain.Transl Behav Med. 2012 Mar;2(1):82-92. doi: 10.1007/s13142-011-0107-2. Transl Behav Med. 2012. PMID: 22924084 Free PMC article. Review.
-
Coexistence of Alterations of Gastrointestinal Function and Mechanical Allodynia in the Reserpine-Induced Animal Model of Fibromyalgia.Dig Dis Sci. 2019 Sep;64(9):2538-2547. doi: 10.1007/s10620-019-05577-8. Epub 2019 Mar 14. Dig Dis Sci. 2019. PMID: 30874990
-
Fibromyalgia: from pathophysiology to therapy.Nat Rev Rheumatol. 2011 Jul 19;7(9):518-27. doi: 10.1038/nrrheum.2011.98. Nat Rev Rheumatol. 2011. PMID: 21769128 Review.
-
Prevalence of the fibromyalgia phenotype in patients with spine pain presenting to a tertiary care pain clinic and the potential treatment implications.Arthritis Rheum. 2013 Dec;65(12):3285-92. doi: 10.1002/art.38178. Arthritis Rheum. 2013. PMID: 24022710 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials